• Outlook Therapeutics, Inc. (NASDAQ:OTLK) Receives Consensus Recommendation of "Moderate Buy" from Analysts

    Source: Buzz FX / 13 Jan 2025 03:50:15   America/Chicago


    Outlook Therapeutics, Inc. (NASDAQ:OTLK) Receives Consensus Recommendation of "Moderate Buy" from Analysts Written by MarketBeat January 13, 2025 Share Link copied to clipboard. Outlook Therapeutics, Inc.
    Read more...
Share on,